Article
Molecular genetic tests for JAK2V617F, Exon12_JAK2 and MPLW515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasms.
Journal of clinical pathology - 1 Feb 2014
dos Santos Marcos Tadeu, Mitne-Neto Miguel, Miyashiro Kozue, Chauffaille Maria de Lourdes L Ferrari, Rizzatti Edgar Gil
Abstract excerpt
Polycythaemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (MF), are the most common myeloproliferative neoplasms (MPN) in patients without the BCR-ABL1 gene rearrangement. They are caused by clonal expansion of haematopoietic stem cells and share, as a diagnostic criterion, the identification of JAK2V617F mutation. Classically, when other clinical criteria are present, a JAK2V617F...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
